HTX 0.00% 0.1¢ healthlinx limited

gcrc on ovplex commercial ovarian cancer, page-3

  1. 310 Posts.
    lightbulb Created with Sketch. 1
    Ok. That took two Google searches to find it.

    GCRC Statement on OvPlex Commercial Ovarian Cancer Detection Assay
    Issued: 28 November 2008
    Up-dated: 11 March 2010

    The article is useful in understanding issues affecting womens health, thanks to erinneptune for posting it. Please note the date of the statement and the date of last update. It would be good to know if the issues identified in the statement are addressed in recent announcements by HTX ie over the past 15 months. I have read the ASX announcements but need to reread to comment further.

    I am not a medico, DYOR
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.